Starting from the 2028 Los Angeles (LA) Olympics, transgender women will be barred from competing in women's events.The International Olympic Committee (IOC) announced this decision following an executive committee meeting on Thursday. The new policy
2028 LA Olympics: New IOC Rules Ban Transgender Women from Competing in Women's Events
SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm announced on Thursday that its innovative epilepsy drug, Cenobamate (marketed as Yifurui in China), has officially launched in China, with initial prescriptions being filled at major hospitals across the country.This milestone comes appro
Dialysis Unit Certification Not Just a Label but a “Survival Signal”… Mortality Risk Down 10%

Dialysis Unit Certification Not Just a Label but a “Survival Signal”… Mortality Risk Down 10%

A study has found that patients receiving hemodialysis at officially certified dialysis centers in Asia face a significantly lower risk of death.The findings confirm the effectiveness of the “Excellent Dialysis Unit Certification Program” implemented
How to Spot Hidden Oral Tumors in Cats: Essential Guide for Pet Owners

How to Spot Hidden Oral Tumors in Cats: Essential Guide for Pet Owners

Detecting oral tumors in cats can be difficult for pet owners, often resulting in delayed diagnosis. By the time these tumors are discovered, the lesions may already be significantly advanced, underscoring the importance of comprehensive pre-surgical
2026 Internet User Survey: How OTT and YouTube Are Transforming TV Viewing Habits in Asia

2026 Internet User Survey: How OTT and YouTube Are Transforming TV Viewing Habits in Asia

A new study shows a significant shift in how viewers consume video content, with more users turning to YouTube and OTT platforms on their televisions.TV users are increasingly watching YouTube and OTT content on their televisions, with online video v
1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

The initiative to combat infectious diseases in South Korea, sparked by a 1 trillion KRW (about 663 million USD) medical donation from the family of the late Samsung Chairman Lee Kun-hee, is gaining significant momentum.From Thursday to Friday (March
How Wonju's 150 Billion KRW AI Aesthetic Medical Device Project Will Transform the Beauty Sector by 2030

How Wonju's 150 Billion KRW AI Aesthetic Medical Device Project Will Transform the Beauty Sector by 2030

Wonju, a city in Gangwon Province, is set to invest over 20 billion KRW (about 13.2 million USD) in the next five years to revolutionize its local beauty and medical device industries.The city has secured approximately 15 billion KRW (about 9.9 milli
TWS: The K-Pop Sensation Named in Rolling Stone's 2026 Future 25 List

TWS: The K-Pop Sensation Named in Rolling Stone's 2026 Future 25 List

K-pop sensation TWS has been hailed as a frontrunner in shaping the future of the global music industry.Rolling Stone, the iconic American music magazine, unveiled its annual Future 25 list on its website on Wednesday. This coveted roster spotlights
Neurophet Partners with ALZ-NET: Revolutionizing Alzheimer's Diagnosis with AI Technology

Neurophet Partners with ALZ-NET: Revolutionizing Alzheimer's Diagnosis with AI Technology

Neurophet, a leading artificial intelligence (AI) company specializing in brain disease diagnosis and treatment, announced on Thursday that it has signed a Memorandum of Understanding (MOU) with the Alzheimer's Network for Treatment and Diagnostic Ex
Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi, a biotech company developing a novel drug pipeline for non-small cell lung cancer (NSCLC), announced on Thursday that it has received approval for modifications to the clinical trial plan for its drug candidate VRN110755.The Phase 1/2 clinic

© Copyright by News1. All Rights Reserved.